World

London's Eurostar train services resume after power failure caused cancellations

Dec 31, 2025

London [UK], December 31: Eurostar train services through the Channel Tunnel from London to mainland Europe were expected to resume later on Tuesday after an earlier power failure saw the Channel Tunnel closed, the operator of the tunnel said.
Eurostar previously said all of its London to Europe services for the day were cancelled, but it later said trains would resume after the tunnel was partially reopened. However, it urged customers to rebook travel for a different date and not to come to London St Pancras station if their train's cancellation was confirmed.
A problem with the overhead power supply and a failed LeShuttle train blocked all routes earlier on Tuesday, causing travel chaos for thousands trying to get away to celebrate the new year.
LeShuttle is also affected, but the operator said earlier on Tuesday its services between Folkestone and Calais were resuming while warning of six-hour delays at the Folkestone terminal. The Channel Tunnel accommodates Eurostar services as well as LeShuttle vehicle-carrying trains between the UK and France.
A spokesperson for the Department for Transport said on Tuesday afternoon: "Eurotunnel is working with operators to resume some services while repairs to overhead electrical cables in the Channel Tunnel are ongoing, however significant disruption is likely for the remainder of the day."
Source: Qatar Tribune

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026